USA |
1998 |
The Drug Enforcement Administration has placed sibutramine for the management of obesity, in Schedule IV of the Controlled Substances Act. This scheduling is based on the low potential for abuse of sibutramine and the fact that it has a currently accepted medical use in treatment in the United States. (Reference: Federal Register 63(28): 6862 (1998).) |